165 related articles for article (PubMed ID: 35611273)
1. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.
DeWire M; Lazow M; Campagne O; Leach J; Fuller C; Senthil Kumar S; Stanek J; de Blank P; Hummel TR; Pillay-Smiley N; Salloum R; Stevenson CB; Baxter P; Gass D; Goldman S; Leary SES; Carle A; Mikael L; Crabtree D; Chaney B; Lane A; Drissi R; Stewart CF; Fouladi M
Neurooncol Adv; 2022; 4(1):vdac055. PubMed ID: 35611273
[TBL] [Abstract][Full Text] [Related]
2. A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study.
DeWire MD; Fuller C; Campagne O; Lin T; Pan H; Young Poussaint T; Baxter PA; Hwang EI; Bukowinski A; Dorris K; Hoffman L; Waanders AJ; Karajannis MA; Stewart CF; Onar-Thomas A; Fouladi M; Dunkel IJ
Clin Cancer Res; 2021 May; 27(9):2442-2451. PubMed ID: 33547201
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire M; Fuller C; Hummel TR; Chow LML; Salloum R; de Blank P; Pater L; Lawson S; Zhu X; Dexheimer P; Carle AC; Kumar SS; Drissi R; Stevenson CB; Lane A; Breneman J; Witte D; Jones BV; Leach JL; Fouladi M
J Neurooncol; 2020 Sep; 149(3):511-522. PubMed ID: 33034839
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.
Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M
J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
Hipp SJ; Goldman S; Kaushal A; Krauze A; Citrin D; Glod J; Walker K; Shih JH; Sethumadhavan H; O'Neill K; Garvin JH; Glade-Bender J; Karajannis MA; Atlas MP; Odabas A; Rodgers LT; Peer CJ; Savage J; Camphausen KA; Packer RJ; Figg WD; Warren KE
J Neurooncol; 2020 Sep; 149(3):437-445. PubMed ID: 33040274
[TBL] [Abstract][Full Text] [Related]
6. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Su JM; Murray JC; McNall-Knapp RY; Bowers DC; Shah S; Adesina AM; Paulino AC; Jo E; Mo Q; Baxter PA; Blaney SM
Pediatr Blood Cancer; 2020 Jun; 67(6):e28283. PubMed ID: 32285998
[TBL] [Abstract][Full Text] [Related]
7. Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies: Arms A and B of the AcSé-ESMART Trial.
Bautista F; Paoletti X; Rubino J; Brard C; Rezai K; Nebchi S; Andre N; Aerts I; De Carli E; van Eijkelenburg N; Thebaud E; Corradini N; Defachelles AS; Ducassou S; Morscher RJ; Vassal G; Geoerger B
J Clin Oncol; 2021 Nov; 39(32):3546-3560. PubMed ID: 34347542
[TBL] [Abstract][Full Text] [Related]
8. Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG.
Tinkle CL; Broniscer A; Chiang J; Campagne O; Huang J; Orr BA; Li X; Patay Z; Zhang J; Baker SJ; Merchant TE; Jain V; Onar-Thomas A; Stewart CF; Wetmore C; Gajjar A
Neurooncol Adv; 2021; 3(1):vdab179. PubMed ID: 34993482
[TBL] [Abstract][Full Text] [Related]
9. A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy.
Weinberg BA; Wang H; Witkiewicz AK; Marshall JL; He AR; Vail P; Knudsen ES; Pishvaian MJ
J Pancreat Cancer; 2020; 6(1):45-54. PubMed ID: 32642630
[No Abstract] [Full Text] [Related]
10. Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).
Monje M; Cooney T; Glod J; Huang J; Peer CJ; Faury D; Baxter P; Kramer K; Lenzen A; Robison NJ; Kilburn L; Vinitsky A; Figg WD; Jabado N; Fouladi M; Fangusaro J; Onar-Thomas A; Dunkel IJ; Warren KE
Neuro Oncol; 2023 Dec; 25(12):2262-2272. PubMed ID: 37526549
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.
Baxter PA; Su JM; Onar-Thomas A; Billups CA; Li XN; Poussaint TY; Smith ER; Thompson P; Adesina A; Ansell P; Giranda V; Paulino A; Kilburn L; Quaddoumi I; Broniscer A; Blaney SM; Dunkel IJ; Fouladi M
Neuro Oncol; 2020 Jun; 22(6):875-885. PubMed ID: 32009149
[TBL] [Abstract][Full Text] [Related]
12. Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children's Oncology Group phase I consortium study.
Mueller S; Cooney T; Yang X; Pal S; Ermoian R; Gajjar A; Liu X; Prem K; Minard CG; Reid JM; Nelson M; Haas-Kogan D; Fox E; Weigel BJ
Neurooncol Adv; 2022; 4(1):vdac073. PubMed ID: 35733515
[TBL] [Abstract][Full Text] [Related]
13. A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors.
Geoerger B; Bourdeaut F; DuBois SG; Fischer M; Geller JI; Gottardo NG; Marabelle A; Pearson ADJ; Modak S; Cash T; Robinson GW; Motta M; Matano A; Bhansali SG; Dobson JR; Parasuraman S; Chi SN
Clin Cancer Res; 2017 May; 23(10):2433-2441. PubMed ID: 28432176
[No Abstract] [Full Text] [Related]
14. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
15. Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.
Gardner SL; Tarapore RS; Allen J; McGovern SL; Zaky W; Odia Y; Daghistani D; Diaz Z; Hall MD; Khatib Z; Koschmann C; Cantor E; Kurokawa R; MacDonald TJ; Aguilera D; Vitanza NA; Mueller S; Kline C; Lu G; Allen JE; Khatua S
Neurooncol Adv; 2022; 4(1):vdac143. PubMed ID: 36382108
[TBL] [Abstract][Full Text] [Related]
16. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.
Manley PE; Trippett T; Smith AA; Macy ME; Leary SES; Boklan J; Cohen KJ; Goldman S; Kilburn LB; Dhall G; Devin J; Herzog CE; Partap S; Fauchet F; Badreddine E; Bernard JP; Chi SN
Pediatr Blood Cancer; 2018 Sep; 65(9):e27217. PubMed ID: 29750396
[TBL] [Abstract][Full Text] [Related]
17. Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
Müller K; Schlamann A; Guckenberger M; Warmuth-Metz M; Glück A; Pietschmann S; Wawer A; Kortmann RD; Kramm C; von Bueren AO
Strahlenther Onkol; 2014 Apr; 190(4):377-81. PubMed ID: 24638239
[TBL] [Abstract][Full Text] [Related]
18. Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR
Bardia A; Modi S; Oliveira M; Cortes J; Campone M; Ma B; Dirix L; Weise A; Hewes B; Diaz-Padilla I; Han Y; Deshpande P; Samant TS; Lorenc KR; He W; Su F; Chavez-MacGregor M
Clin Cancer Res; 2020 Dec; 26(24):6417-6428. PubMed ID: 32998962
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.
Qi J; Esfahani DR; Huang T; Ozark P; Bartom E; Hashizume R; Bonner ER; An S; Horbinski CM; James CD; Saratsis AM
Acta Neuropathol Commun; 2019 May; 7(1):75. PubMed ID: 31092287
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.
Fangusaro J; Cefalo MG; Garré ML; Marshall LV; Massimino M; Benettaib B; Biserna N; Poon J; Quan J; Conlin E; Lewandowski J; Simcock M; Jeste N; Hargrave DR; Doz F; Warren KE
Front Oncol; 2021; 11():660892. PubMed ID: 34168987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
